Drug Profile
Morphine oral - CeNeS
Alternative Names: Morphine OSATLatest Information Update: 15 Oct 2002
Price :
*
At a glance
- Originator CeNeS Pharmaceuticals
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 11 Sep 2013 Biomarkers information updated
- 15 Oct 2002 Discontinued - Clinical-Phase-Unknown for Pain in United Kingdom (PO)
- 16 Dec 1999 Core Group has merged with CeNeS Limited to form CeNeS Pharmaceuticals